Medications

New monoclonal antibody shows promise for severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health ...

Immunology

Scientists unearth cell 'checkpoint' that stops allergic diseases

Scientists from Trinity College Dublin have made a significant breakthrough in understanding the regulation of immune cells that play a pivotal role in allergic diseases such as asthma and eczema. They have identified a 'checkpoint' ...

Diseases, Conditions, Syndromes

Research revelation could shape future long-term treatment of asthma

A new study reveals that the progressive loss of lung function in asthma sufferers could be entirely independent of the effects of inflammation. The findings have significant implications for the long-term treatment of asthma.

Diseases, Conditions, Syndromes

'Dickensian' lung disease rates on the rise in UK pensioners

The number of people diagnosed with bronchiectasis, a lung condition thought to be a 'disease of the past', has risen considerably in the past decade and now affects more than 1% of UK pensioners, finds a new study by UCL, ...

page 3 from 14